A phase I study of 9-Nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors

1. Michaelson, M.D.
2. Ryan, D.P.
3. Fuchs, C.S.
4. Supko, J.G.
5. Garcia-Carbonero, R.
6. Eder, J.P.
7. Clark, J.W.